Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 181 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

Huntington Disease Phase3 Argentina
Australia
Belgium
Bulgaria
Canada
China
Colombia
Czechia
Denmark
France
Germany
Hungary
Israel
Italy
Japan
Netherlands
Poland
Portugal
Romania
Saudi Arabia
Slovakia
South Korea
Spain
Switzerland
Taiwan
United Kingdom
United States
View all

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Geographic Atrophy Secondary to Age-related Macular Degeneration Phase2 Argentina
Australia
Brazil
Bulgaria
Canada
Colombia
Czechia
France
Germany
Hungary
Italy
Japan
Poland
Puerto Rico
Romania
Spain
United Kingdom
United States
View all

Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea

Hidradenitis Suppurativa, Pediatric Plaque Psoriasis, Juvenile Idiopathic Arthritis South Korea

Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)

Metastatic Prostate Cancer China

A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

Relapsing Multiple Sclerosis Germany

Remibrutinib in Real-world Clinical Practice - a US Sub-study

Chronic Spontaneous Urticaria United States

A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients

Chronic Spontaneous Urticaria United States

Remibrutinib in Real-world Clinical Practice

Chronic Spontaneous Urticaria United States

Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice

Breast Cancer Russia

Real-world Secukinumab Outcomes in Canadian HS Patients

Hidradenitis Suppurativa Canada